Document Detail

Strategies to Prevent Radial Artery Occlusion After Transradial PCI.
MedLine Citation:
PMID:  24890765     Owner:  NLM     Status:  In-Data-Review    
Radial artery occlusion (RAO) is the most common structural consequence of transradial access (TRA) with an estimated incidence ranging from 2-10 %. Its occurrence is free of any major clinical consequences, especially at rest, with most if not all cases of digital ischemia occurring as a result of embolization, rather than RAO. The incidence of RAO is unacceptably high if "best practices" are not followed. Strategies to prevent RAO need to be implemented to preserve radial artery patency in order to exploit other benefits of TRA.
Samir B Pancholy
Related Documents :
2218075 - Transcatheter arterial embolization and chemoembolization induce the production of free...
25107725 - New frontiers in aortic therapy: focus on deep hypothermic circulatory arrest.
10511085 - Preoperative embolization of meningiomas with pial supply: successful treatment of two ...
7586965 - Pelvic arterial embolization following hysterectomy and bilateral internal iliac artery...
3571755 - Pitfalls in the diagnosis of periprosthetic valvular regurgitation by pulsed doppler ec...
11568875 - Aortic valve-sparing operations for aortic root aneurysm.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  16     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-06-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  505     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medical and interventional options to treat pulmonary embolism.
Next Document:  Emerging therapeutic approaches to treat dyslipidemia.